Infant Exposure to MS Drugs via Breastfeeding: New Data
Infant exposure to monoclonal antibodies used to treat MS via breast milk does not negatively affect health or development out to 3 years, a new study shows.
Stay updated with breaking news from Edithl Graham. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Infant exposure to monoclonal antibodies used to treat MS via breast milk does not negatively affect health or development out to 3 years, a new study shows.
For women with multiple sclerosis (MS), there is no increased relapse rate after fertility treatment (FT).
Contrary to previous research, a new study suggests fertility treatments pose little risk of MS relapse in women who undergo fertility treatments, suggesting it may be time for new clinical guidance.
An MS relapse is no more likely in women after fertility treatment than before such treatment, a study that may "provide reassurance" finds.
Mean annualized relapse rate not different before vs after controlled ovarian stimulation.